Last checked at 17 Jun 2021 15:47
17 June 2021
Directa Plus plc
("Directa Plus" or the "Company")
Grant of Options
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that, on 15 June 2021, the Board approved the grant of performance-related options over a total of 150,000 ordinary shares of 0.25 pence each in the Company (the "Options") to Giorgio Bonfanti, Chief Financial Officer under the 2020 Employees' Share Scheme.
Subject to the satisfaction of criteria related to the Company's share price performance over the period, the Options (or a portion thereof) will vest in three equal tranches on each of the first, second and third anniversaries of the date of award. 75 per cent. of the vested Options may be exercised after the third anniversary and the remaining 25 per cent. may be exercised after the fourth anniversary. The exercise price of each Option will be 118.20 pence, which is the average closing bid price of the Company's shares on the London Stock Exchange plc for the 30 days before the date of grant.
For further information please visit http://www.directa-plus.com/ or contact:
Directa Plus plc | +39 02 36714458 |
Giulio Cesareo, CEO Giorgio Bonfanti, CFO | |
Cenkos Securities plc (Nominated Adviser and Joint Broker) | +44 131 220 6939 |
Neil McDonald Pete Lynch |
|
|
|
N+1 Singer (Joint Broker) | +44 20 7496 3069 |
Rick Thompson Phil Davies |
|
|
|
Tavistock (Financial PR and IR) | +44 20 7920 3150 |
Simon Hudson Heather Armstrong |
|
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product), textiles (based on our G+® products) and, more recently, lithium-sulphur batteries. In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products. All our products are hypoallergenic, non-toxic and sustainably produced.
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||
a) | Name
| Giorgio Bonfanti | |
2 | Reason for notification
| ||
a) | Position/Status
| Chief Financial Officer | |
b) | Initial notification/Amendment
| Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
a) | Name
| Directa Plus plc | |
b) | LEI
| 213800X2DQST3K5ND898 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
a) | Description of the financial instrument, type of instrument
| Grant of options under the Directa Plus plc 2020 Employees' Share Scheme | |
Identification code
| ISIN: GB00BSM98843 | ||
b) | Nature of the transaction
| Award of Share Options
| |
c) | Price(s) and volume(s)
| Price | Volume |
118.2p | 150,000 | ||
d) | Aggregated information - Aggregated volume - Price
| N/A Single Transaction
| |
e) | Date of the transaction
| 15 June 2021 | |
f) | Place of the transaction
| London Stock Exchange, AIM | |
-ends-